207 related articles for article (PubMed ID: 28283362)
1. SYNTAX score II in patients with coronary artery disease undergoing percutaneous mitral repair with the MitraClip.
Obeid S; Attinger-Toller A; Taramasso M; Pedrazzini G; Suetsch G; Landolt F; Karbeyaz F; Rodriguez H; Sürder D; Moccetti T; Nietlispach F; Maisano F
Int J Cardiol; 2017 Jun; 236():375-380. PubMed ID: 28283362
[TBL] [Abstract][Full Text] [Related]
2. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
Dörr O; Walther C; Liebetrau C; Keller T; Sommer T; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
Clin Cardiol; 2018 Sep; 41(9):1164-1169. PubMed ID: 29896861
[TBL] [Abstract][Full Text] [Related]
4. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry.
Ohno Y; Attizzani GF; Capodanno D; Cannata S; Dipasqua F; Immé S; Barbanti M; Ministeri M; Caggegi A; Pistritto AM; Chiarandà M; Ronsivalle G; Giaquinta S; Farruggio S; Mangiafico S; Scandura S; Tamburino C; Capranzano P; Grasso C
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1246-55. PubMed ID: 24939944
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
Spieker M; Hellhammer K; Wiora J; Klose S; Zeus T; Jung C; Saeed D; Horn P; Kelm M; Westenfeld R
Catheter Cardiovasc Interv; 2019 Mar; 93(4):699-706. PubMed ID: 30328258
[TBL] [Abstract][Full Text] [Related]
6. Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction.
Gyoten T; Schenk S; Rochor K; Herwig V; Harnath A; Grimmig O; Just S; Fritzsche D; Messroghli D
ESC Heart Fail; 2020 Aug; 7(4):1781-1790. PubMed ID: 32445540
[TBL] [Abstract][Full Text] [Related]
7. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience.
Taramasso M; Denti P; Buzzatti N; De Bonis M; La Canna G; Colombo A; Alfieri O; Maisano F
Eur J Cardiothorac Surg; 2012 Dec; 42(6):920-6. PubMed ID: 22961958
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy.
Giannini C; Fiorelli F; Colombo A; De Carlo M; Weisz SH; Agricola E; Godino C; Castriota F; Golino P; Petronio AS
Int J Cardiol; 2016 Nov; 223():574-580. PubMed ID: 27561163
[TBL] [Abstract][Full Text] [Related]
9. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery.
Ro SK; Kim JB; Jung SH; Choo SJ; Chung CH; Lee JW
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1092-7. PubMed ID: 22944085
[TBL] [Abstract][Full Text] [Related]
10. Mitral valve repair versus replacement in patients with ischaemic mitral regurgitation and depressed ejection fraction: risk factors for early and mid-term mortality†.
Lio A; Miceli A; Varone E; Canarutto D; Di Stefano G; Della Pina F; Gilmanov D; Murzi M; Solinas M; Glauber M
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):64-9. PubMed ID: 24676552
[TBL] [Abstract][Full Text] [Related]
11. Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.
Paranskaya L; D'Ancona G; Bozdag-Turan I; Akin I; Kische S; Turan GR; Rehders T; Ortak J; Nienaber CA; Ince H
Catheter Cardiovasc Interv; 2013 Mar; 81(4):609-17. PubMed ID: 22887450
[TBL] [Abstract][Full Text] [Related]
12. Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
Dörr O; Walther C; Liebetrau C; Keller T; Tabert H; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
Clin Cardiol; 2018 Apr; 41(4):481-487. PubMed ID: 29663512
[TBL] [Abstract][Full Text] [Related]
13. MitraClip implantation for high risk patients with severe mitral regurgitation: the Sheba experience.
Koifman E; Fefer P; Hay I; Feinberg M; Maor E; Guetta V
Isr Med Assoc J; 2014 Feb; 16(2):91-5. PubMed ID: 24645227
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum biomarker profiles after percutaneous mitral valve repair with the MitraClip system.
Yoon JN; Frangieh AH; Attinger-Toller A; Gruner C; Tanner FC; Taramasso M; Corti R; Lüscher TF; Ruschitzka F; Bettex D; Maisano F; Gaemperli O
Cardiol J; 2016; 23(4):384-92. PubMed ID: 27296161
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure?
Berardini A; Biagini E; Saia F; Stolfo D; Previtali M; Grigioni F; Pinamonti B; Crimi G; Salvi A; Ferrario M; De Luca A; Gazzoli F; Bacchi Reggiani ML; Raineri C; Sinagra G; Rapezzi C
Int J Cardiol; 2017 Feb; 228():191-197. PubMed ID: 27875721
[TBL] [Abstract][Full Text] [Related]
16. Initial French experience of percutaneous mitral valve repair with the MitraClip: a multicentre national registry.
Armoiry X; Brochet E; Lefevre T; Guerin P; Dumonteil N; Himbert D; Cormier B; Piriou N; Gautier M; Messika-Zeitoun D; Romano M; Rioufol G; Warin Fresse K; Boudou N; Leclercq F; Bedossa M; Obadia JF
Arch Cardiovasc Dis; 2013 May; 106(5):287-94. PubMed ID: 23769403
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment.
Geis N; Raake P; Lewening M; Mereles D; Chorianopoulos E; Frankenstein L; Katus HA; Bekeredjian R; Pleger ST
Acta Cardiol; 2018 Aug; 73(4):378-386. PubMed ID: 29161956
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).
Dörr O; Walther C; Liebetrau C; Keller T; Ortlieb RM; Boeder N; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
Clin Cardiol; 2018 Nov; 41(11):1474-1479. PubMed ID: 30284299
[TBL] [Abstract][Full Text] [Related]
19. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry.
Attizzani GF; Ohno Y; Capodanno D; Cannata S; Dipasqua F; Immé S; Mangiafico S; Barbanti M; Ministeri M; Cageggi A; Pistritto AM; Giaquinta S; Farruggio S; Chiarandà M; Ronsivalle G; Schnell A; Scandura S; Tamburino C; Capranzano P; Grasso C
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):74-82. PubMed ID: 25499300
[TBL] [Abstract][Full Text] [Related]
20. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes.
Conradi L; Treede H; Rudolph V; Graumüller P; Lubos E; Baldus S; Blankenberg S; Reichenspurner H
Eur J Cardiothorac Surg; 2013 Sep; 44(3):490-6; discussion 496. PubMed ID: 23401496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
